Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
Titel:
Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
Auteur:
Beitsch, Peter Whitworth, Pat Baron, Paul Rotkis, Michael C. Mislowsky, Angela M. Richards, Paul D. Murray, Mary K. Pellicane, James V. Dul, Carrie L. Nash, Charles H. Stork-Sloots, Lisette Snoo, Femke de Untch, Sarah Lee, Laura A.